A-366833: A novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane α4β2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models-Reference-Cited by-同舟云学术

A-366833: A novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane α4β2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models

Published:2007-10 Issue:8 Volume:74 Page:1253-1262
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Ji Jianguo,Bunnelle William H.,Anderson David J.,Faltynek Connie,Dyhring Tino,Ahring Philip K.,Rueter Lynne E.,Curzon Peter,Buckley Michael J.,Marsh Kennan C.,Kempf-Grote Anita,Meyer Michael D.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference48 articles.

1. Neuropathic pain: molecular complexity underlies continuing unmet medical need;Kennedy;J Med Chem,2007

2. Neuronal nicotinic acetylcholine receptors: structure revelations, targets identifications, and therapeutic inspirations;Jensen;J Med Chem,2005

3. Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity;Bunnelle;Curr Med Chem,2004

4. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics;Decker;Curr Top Med Chem,2004

5. Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain;Decker;Drug Dev Res,2006

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies;Pharmaceuticals;2023-09-27

2. Cyanopyridine as a privileged scaffold in drug discovery;Privileged Scaffolds in Drug Discovery;2023

3. Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy;eNeurologicalSci;2022-09

4. Nicotine’ actions on energy balance: Friend or foe?;Pharmacology & Therapeutics;2021-03

5. The nicotinic modulation of pain;Pakistan Journal of Pharmaceutical Sciences;2020-01-01